Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide vs Dapagliflozin in ADHF
NCT06535529Phase 3Recruiting
- Sponsor
- Helwan University
- Start
- Aug 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetazolamide, dapagliflozin in acute decompensated heart failure (ADHF), sponsored by Helwan University. Started Aug 2024; status: recruiting.
02
Drugs
acetazolamidedapagliflozin
03
Conditions
acute decompensated heart failure (ADHF)
Beyond the preview
Go deeper on NCT06535529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06535529.